IBM Gains Momentum in Life Sciences

Chemical Computing Group, Tripos and Wavefunction Among Companies Enabling Applications to Run on IBM Systems

Select a topic or year

NEW ORLEANS, LA - 24 Mar 2003: IBM today announced that nearly 200 of the industry's leading life sciences applications have now been ported to IBM eServer systems.

At the 2003 American Chemical Society Conference, three leading chemistry solution providers, Chemical Computing Group (CCG), Tripos and Wavefunction, discussed plans to port their flagship applications to IBM eServer* systems running Linux**, UNIX*** and Windows*** operating systems. CCG will also support IBM's thinnest server, the eServer BladeCenter* that provides increased compute power in minimal floor space. IBM will work with these companies to market and sell the joint solutions to pharmaceutical and biotechnology firms, and government-sponsored research organizations.

"Today more than ever chemistry and cheminformatics solution providers need information technology partners that can help them deliver total solutions to the market faster," said Anne-Marie Derouault, director, Alliances and Distribution Channel Management, IBM Life Sciences. "Life sciences organizations of every size want powerful, yet flexible applications and infrastructures that will help them transform research processes and bring new efficiencies to drug discovery. IBM's new relationships with CCG, Tripos and Wavefunction are built on complementary technology strengths that can help our customers advance scientific discovery."

CCG's entire suite of drug discovery software applications, known collectively as the Molecular Operating Environment (MOE)***, has been adapted to exploit the power of IBM eServer pSeries* systems running AIX*, IBM's UNIX operating system, and IBM eServer xSeries* systems running Linux with IBM DB2* database software. CCG applications also will support IBM's IntelliStation* workstations and ThinkPad* notebook computers.

MOE is a combined applications environment and methodology development platform that integrates visualization, simulation and application development in one package. It contains a broad range of scientific applications in such areas as cheminformatics, high-throughput discovery, protein modeling, structure-based design and bioinformatics.

Tripos is collaborating with IBM to enable Tripos FlexX***, a virtual screening application within its SYBYL*** drug discovery platform, and UNITY***, a search and analysis system for chemical databases, to run on IBM's eServer 1350 Linux Cluster.

This year, Wavefunction's Spartan*** family of molecular modeling software will support IBM eServer pSeries systems, along with IBM's IntelliStation* and ThinkPad* products. Spartan's molecular mechanics and quantum chemical calculations provide molecular properties and data such as the optimized structures, reaction and activations energies, and conformational distributions of chemicals.

IBM offers the industry's broadest portfolio of information technologies and services for life sciences, ranging from high-performance computing and storage systems to infrastructure software for managing large, disparate data sets, data and application integration, and collaboration, as well as consulting and implementation services. These offerings are designed to address the needs of organizations ranging from small and mid-sized biotechnology companies and universities doing biomedical research to the largest global pharmaceutical enterprises.

Numerous other life sciences solution providers now offer applications that have been ported and tested to run on IBM platforms. Applications include ActivityBase***, AMBER***, BLAST***, DiscoveryChannel***, Discovery Warehouse***, First Discovery***, GAMESS***, Jaguar***, MacroModel***, Phrap***, Phred***, WUBLAST*** and others.

Related XML feeds
Topics XML feeds
Services and solutions